LynneMarieKnowlesMD

PubMed

• Simplifying the preevacuation testing strategy for patients with molar pregnancy.
  Lynne M. Knowles, Richard D. Drake, Raheela Ashfaq, Diego H. Castrillon, David Miller, John O. Schorge> ;The Journal of Reproductive Medicine. 2007 Aug 1
• 14 citations
  PROTEOMIC BIOMARKER IDENTIFICATION FOR DIAGNOSIS OF EARLY RELAPSE IN OVARIAN CANCER
  Jung Hun Oh, Animesh Nandi, Prem Gurnani, Lynne M. Knowles, John O. Schorge, Kevin P. Rosenblatt, Jean Gao> ;Journal of Bioinformatics and Computational Biology. 2006 Dec 1
• 8 citations
  Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
  Shana N. Wingo, Lynne M. Knowles, Kelley Carrick, David Miller, John O. Schorge> ;American Journal of Obstetrics and Gynecology. 2006 May 1
• 7 citations
  Diagnosis of Early Relapse in Ovarian Cancer Using Serum Proteomic Profiling
  Jung Hun Oh, Jean Gao, Animesh Nandi, Prem Gurnani, Lynne M. Knowles, John O. Schorge> ;Genome Informatics. International Conference on Genome Informatics. 2005 Jan 1
• 36 citations
  Adenocarcinoma of the cervix
  John O. Schorge, Lynne M. Knowles, Jayanthi S. Lea> ;Current Treatment Options in Oncology. 2004 Apr 1
• Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells.
  Knowles LM, Milner JA> ;Nutr Cancer. 1998-01-01
• Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch.
  Richardson, R. J., Dixon, J., Malhotra, S., Hardman, M. J., Knowles, L., Boot-Handford, R. P., Shore, P., Whitmarsh, A., Dixon, M. J.> ;Nat Genet. 2006 Nov
• Allyl sulfides modify cell growth.
  Knowles, L. M., Milner, J. A.> ;Drug Metabol Drug Interact. 2000
• Diallyl disulfide inhibits p34(cdc2) kinase activity through changes in complex formation and phosphorylation.
  Knowles, L. M., Milner, J. A.> ;Carcinogenesis. 2000 Jun
• Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells.
  Knowles, L. M., Milner, J. A.> ;J Nutr. 2003 Sep
• Possible mechanism by which allyl sulfides suppress neoplastic cell proliferation.
  Knowles, L. M., Milner, J. A.> ;J Nutr. 2001 Mar
• Flavonoids suppress androgen-independent human prostate tumor proliferation.
  Knowles, L. M., Zigrossi, D. A., Tauber, R. A., Hightower, C., Milner, J. A.> ;Nutr Cancer. 2000
• The anti-angiogenic peptide anginex disrupts the cell membrane.
  Pilch, J., Franzin, C. M., Knowles, L. M., Ferrer, F. J., Marassi, F. M., Ruoslahti, E.> ;J Mol Biol. 2006 Mar 3
• A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2.
  Knowles, L. M., Axelrod, F., Browne, C. D., Smith, J. W.> ;J Biol Chem. 2004 Jul 16
• Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer.
  Knowles, L. M., Smith, J. W.> ;BMC Genomics. 2007
• CLT1 targets angiogenic endothelium through CLIC1 and fibronectin.
  Knowles, L. M., Malik, G., Hood, B. L., Conrads, T. P., Pilch, J.> ;Angiogenesis. 2012 Mar
• Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.
  Malik, G., Knowles, L. M., Dhir, R., Xu, S., Yang, S., Ruoslahti, E., Pilch, J.> ;Cancer Res. 2010 Jun 1
• HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
  Knowles, L. M., Stabile, L. P., Egloff, A. M., Rothstein, M. E., Thomas, S. M., Gubish, C. T., Lerner, E. C., Seethala, R. R., Suzuki, S., Quesnelle, K. M., Morgan, S....> ;Clin Cancer Res. 2009 Jun 01
• Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4.
  Knowles, L. M., Yang, C., Osterman, A., Smith, J. W.> ;J Biol Chem. 2008 Nov 14
• Synthesis of novel beta-lactone inhibitors of fatty acid synthase.
  Richardson, R. D., Ma, G., Oyola, Y., Zancanella, M., Knowles, L. M., Cieplak, P., Romo, D., Smith, J. W.> ;J Med Chem. 2008 Sep 11
• Join now to see all